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Abstract (40-60 words):  Regulation of vascular tone is a complex response that integrates 
multiple signals which allow for blood flow and oxygen supply to appropriately match oxygen 
demand.  Here, we discuss the potential role of intravascular ATP as a primary factor in these 
responses and propose that deficient ATP release may contribute to impairments in vascular 
control exhibited in aged and diseased populations.   
 
Summary (15-20 words): ATP is involved in vascular control during exercise and hypoxia and 
may explain impaired regulation in certain high-risk populations. 
 
Key Words: blood flow, hypoxia, exercise, purine, hyperemia 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
3 
 
INTRODUCTION 
 Appropriate matching of oxygen delivery to tissue metabolic demand occurs largely via 
adjustments in convective oxygen delivery, or more simply, changes in blood flow.  In healthy 
humans, blood flow is linearly correlated with oxygen consumption in tissue beds such as 
cardiac and skeletal muscle and augmentation of oxygen demand (e.g.  muscle contractions) is 
met with a synchronized increase in blood flow and oxygen supply (20).  In the case of 
challenged oxygen supply, as in systemic hypoxia, where hemoglobin oxygen saturation is lower 
than normal, blood flow increases to normalize oxygen delivery (i.e. blood flow × arterial blood 
oxygen content) to the given demand (6,27,30).  Accordingly, any oxygen mismatch evoked by 
either an acute elevation in oxygen demand, reduction in oxygen delivery, or an exacerbated 
combination of both stimuli, results in an elevation in tissue blood flow. 
Absolute tissue blood flow is determined by perfusion pressure and arteriolar resistance.  
During physiological stresses, both determinants of blood flow are modulated and influential; 
however, it is vascular resistance that has greater impact since changes in vessel diameter are 
magnified to the 4
th
 power (Poiseuille’s law).  Arteriolar vascular caliber is controlled by 
multiple input signals including sympathetic vasoconstrictor tone, circulating vasoactive 
hormones or neurotransmitters, transmural pressure, endothelial-derived substances and 
metabolic factors acting on the vessel extra- and intra-luminally.  At the regional and 
microcirculatory level, a great deal of redundancy is observed with regard to regulating net 
vascular tone and this is often evidenced by the failure of pharmacological inhibition of one or 
more vasoactive factors to impair metabolic autoregulation (20).   
Metabolic autoregulation has been the topic of many investigations in both animal and 
human models and the compilation of findings clearly demonstrates an extremely complex 
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control of vascular tone.  Specific vasoactive candidates important in the control of vascular tone 
during physiological stress are often framed against a number of criteria.  First, regarding the 
endogenous molecule, it must be measureable, have inactivation mechanisms, and release should 
occur at the required location and be stimulated during the stress.  Secondly, if the candidate 
molecule is administered exogenously, the vasoactive response should mimic that which occurs 
during the stress.  Finally, inhibiting the vascular action of the molecule should be consistent 
with the proposed hypothesis of vascular regulation (12).  Recent insights gained from our 
laboratory and others demonstrate that intravascular ATP is a candidate molecule that largely 
satisfies these criteria.  Therefore, the purpose of this review is to present the most significant 
and recent data related to the role of intravascular ATP in vascular control of humans including 
the potential sources and stimuli for endogenous release and the signaling pathways underlying 
ATP’s powerful vasoregulatory action.  Finally, we present the postulate that changes in the 
regulation of intravascular ATP and associated vasomotor signaling may contribute to observed 
impairments in vascular control of aged or diseased humans during conditions of oxygen 
mismatch. 
 
INTRAVASCULAR ATP IS MEASURABLE DURING EXERICSE AND HYPOXIA  
 In the late 1960’s, Forrester and Lind reported an increase in venous plasma ATP 
concentrations during exercise in humans (13).  Since that time, our laboratory and others have 
advanced understanding through investigations demonstrating an increase in plasma [ATP] 
during graded intensity whole-body or isolated limb models of exercise in humans 
(4,14,16,25,30).  In general, the observed elevations in intravascular [ATP] are greatest in 
venous blood draining the active muscle and occur in an exercise intensity (and tissue oxygen 
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consumption) dependent manner (Figure 1A-B).  In regard to hypoxia, when humans are 
exposed to low-oxygen content air (~10% fractional inspired O2; O2 saturations ~80%), venous 
plasma [ATP] draining muscle is also elevated in young healthy humans (Figure 1C-D) 
(16,25,30).  Along with increases occurring primarily in the venous circulation,  the degradation 
of ATP via cell-surface ectonucleotideases appears to be rapid (half-life of intravascular ATP < 1 
second) and thus it is likely that it is a local release of ATP within or in close proximity to the 
microcirculation that drives elevations in plasma [ATP] draining skeletal muscle during exercise 
and hypoxia (25,30).   
It is important to note that careful consideration must be made towards reported absolute 
values of plasma [ATP] due to differences in technical measurement (luciferin-luciferase assay 
vs high performance liquid chromatography), sample location (e.g. intravascular microdialysis, 
large and small vessels) and processing (e.g. preservation or “stop” solutions, immediate vs 
delayed measurement) (17).  These discrepant absolute values are apparent in the data 
reproduced in Figure 1.  Also, in these in vivo human studies, samples were obtained from 
vessels either up- (arterial) or down- (venous) stream of the skeletal muscle microcirculation 
where intravascular [ATP] would be greatest and impact vascular tone.  Despite these 
considerations, within a given study, it is well-established that muscle contractions and systemic 
hypoxia increase venous plasma [ATP] draining skeletal muscle in humans (4,13-16,25,30). 
 
FROM WHERE COULD ATP BE RELEASED DURING EXERCISE AND HYPOXIA? 
 In order for intravascular ATP to have a role in vascular control during mismatches in 
oxygen delivery and demand, cellular sources of ATP must be able to release ATP during these 
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stimuli at the required location of the microcirculation.  Potential candidates for the source(s) of 
increased intravascular [ATP] during exercise and hypoxia are discussed below. 
 
Extravascular sources: sympathetic nerves and skeletal muscle cells 
 During systemic hypoxia and moderate to high-intensity exercise, sympathetic nervous 
system activity is increased (20,27).  ATP can be co-released from sympathetic nerves along 
with norepinephrine and thus investigators have questioned whether the nerves may contribute to 
the observed increased plasma [ATP] under these conditions.  Additionally, interstitial [ATP] 
increases during exercise and skeletal muscle itself has also been proposed to be a potential 
source of plasma ATP during muscle contractions (28).  However, given the size of ATP 
molecules, its rapid degradation by ectonucleotidases located on cell surfaces, as well as 
previous findings that intravascular infusion of exogenous ATP does not elevate interstitial 
concentrations suggests vascular smooth muscle and endothelial cells may provide an effective 
barrier that prevents nerve- and/or muscle-released ATP from reaching the intravascular space 
(28).          
Recently, we determined whether acute elevations in sympathetic nervous system activity 
increases venous plasma [ATP] draining skeletal muscle in humans.  Lower body negative 
pressure to elicit baroreflex-mediated activation of the sympathetic nervous system failed to 
increase venous plasma [ATP] both at rest (Figure 2A) and during exercise (Figure 2B) (22).  
Regarding skeletal muscle as a potential source, muscle contractions fail to independently 
increase [ATP] when blood flow is occluded (Figures 2C and 2D).  Thus, the collective data 
indicate that sympathetic nerves and skeletal muscle cells likely do not contribute to the observed 
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increases in plasma [ATP] during exercise or other sympathoexcitatory conditions such as 
systemic hypoxia.   
 
Intravascular and vascular sources: blood cells and endothelial cells 
 Manipulation of forearm blood flow in the aforementioned study not only allowed for 
determination of whether the sympathetic nerves and/or skeletal muscle may be a source of ATP 
but also provided insight as to whether perfusion itself, and therefore supply of erythrocytes, 
other blood cells, and shear stress along endothelial cells is obligatory to observe increased 
venous plasma [ATP] draining skeletal muscle during exercise (22).  When perfusion to actively 
contracting muscle is occluded, plasma [ATP] levels decline to resting values (Figure 2C).  
Additionally, when blood flow to a resting tissue is occluded and then muscle contractions 
commence, plasma [ATP] does not increase (Figure 2D).  Taken together, our findings suggests 
the source of increased plasma [ATP] during exercise is dependent on perfusion and thus from 
cells within or in contact with the blood.  In this context, isolated erythrocytes release significant 
amounts of ATP in response to a variety of stimuli which we discuss in further detail in the 
following section (1,11).  Similarly, vascular endothelial cells, the monolayer of epithelial cells 
capable of releasing a variety of vasoactive substances in isolation, can release ATP under 
similar conditions (2).  While the specific cell source of increased plasma [ATP] draining 
skeletal muscle remains somewhat elusive, collective evidence suggests it is within or in contact 
with the intravascular space. 
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WHAT STIMULATES THE RELEASE OF ATP DURING EXERCISE AND HYPOXIA? 
 In order for ATP to be a candidate molecule involved in the regulation of vascular tone 
during muscle contractions or systemic hypoxia, specific stimuli for ATP release must be present 
during these physiological stresses.  To date, a number of stimuli have been proposed to increase 
intravascular [ATP] under these conditions. 
 
Changes in blood milieu  
 Repeated muscle contractions evoke an increase in metabolism, which results in greater 
oxygen consumption, the production of CO2, and acidosis (4,6,28).  Classic physiology studies 
manipulating hemoglobin concentrations demonstrated that muscle blood flow is more directly 
dependent on changes in oxygen content rather than changes in the partial pressure of oxygen 
(PO2) (31).  In this context, it is important to note both in vitro data in whole blood samples 
(Figure 2E) (18) and plasma measurements of [ATP] from humans (Figure 2F) (16) show a 
strong relationship between increased ATP release and hemoglobin deoxygenation.  Although 
declines in PO2 that accompany exercise and hypoxia may stimulate endothelial cell release of 
ATP independent of erythrocytes (2), there is evidence demonstrating that isolated resistance 
vessels fail to dilate in response to hypoxia without the presence of erythrocytes (8), thus it is 
unlikely that the endothelium is the primary site of ATP release. 
 In addition to deoxygenation that occurs with muscle contractions or systemic hypoxia 
exposure, changes in pH, particularly acidosis can also stimulate ATP release from red blood 
cells (11).  Further, as a result of repeated muscle contractions, increases in blood temperature 
can occur and this may also contribute to ATP release during exercise (21).  The specific ATP 
release pathways from erythrocytes and other cell sources and the various stimuli for these 
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processes continue to be a topic of interest.  Taken together, the combined local metabolic milieu 
resultant from exercise or hypoxia is a stimulus for increased ATP release from intravascular 
sources and would appropriately increase with greater exercise intensity or duration of these 
conditions of oxygen mismatch, as do ATP levels (Figure 1A-B).   
 
Mechanical stresses 
 In addition to the changes in metabolic milieu associated with exercise that have been 
shown to stimulate ATP release, mechanical stimuli during muscle contraction have also been 
associated with increased ATP release.  It is well known that as erythrocytes traverse the 
microcirculation they undergo mechanical deformation, and this has experimentally been shown 
to stimulate ATP release (11).  As skeletal muscles contract, the elevation in extravascular 
pressure causes compression or distortion of the resistance vessels, thus exposing the 
erythrocytes to even greater mechanical stress during exercise.  Endothelial cells also experience 
increased mechanical stimulation during exercise in the form of greater shear stress due to 
elevated blood flow and mechanical distortion as a result of contracting tissue.  Studies in vitro 
demonstrate these factors increase endothelial cell ATP release (2).  Along these lines, we and 
others have shown mechanical stimulation to mimic the compressive forces of a muscle 
contraction (via rhythmic inflation and deflation of a blood pressure cuff) increases venous 
plasma [ATP] (4,15).  It should be noted that in vivo human models cannot determine the cell-
specific source of ATP in these conditions as it is not possible to selectively cause mechanical 
distortion of erythrocytes or endothelial cells.  However, when vasodilators are infused into the 
brachial or femoral artery and increase blood flow and shear stress along endothelial cells 
without changing oxygenation, [ATP] does not increase in the venous effluent (25,30).  Thus, it 
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does not appear that shear-mediated endothelial cell release largely contributes to the increase in 
plasma [ATP] draining skeletal muscle observed during exercise and/or hypoxia.   
 
WHAT ARE THE VASOMOTOR ACTIONS OF EXOGENOUS ATP AND DO THESE 
MIMIC THOSE OF EXERCISE AND HYPOXIA? 
 Historically, when attempting to discern the role for a given substance or signaling 
cascade in vascular control, pharmacological antagonists or physiological maneuvers are utilized 
to inhibit the source or action of the substance in question and determine the possible impact on 
the regulation being studied, for instance exercise hyperemia.  One of the significant challenges 
that we and others have faced in our investigations of ATP is the lack of an appropriate 
pharmacological antagonist to inhibit ATP binding to its respective purinergic receptors (P2).  
Even in animal models, specific pharmacology is limited and thus the data in support of our 
overall hypothesis of vascular regulation are derived from physiological and experimental 
manipulations of the previously discussed stimuli, as well as the unique signaling pathways and 
vasomotor properties of ATP as described below. 
 
Potent Vasodilation 
The potential role for extracellular ATP as a vasoactive molecule in humans was initially 
described in the mid-20
th
 century when observations of increased blood flow were made 
following exogenous ATP intra-arterial infusion (9).  As compared to other purine compounds 
such as adenosine, the potency of ATP is robust, causing significant dilation that mimics levels 
achieved during maximal exercise (Figure 3A) (32).  
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
11 
 
Modulation of Sympathetic Vasoconstriction 
 In addition to the vasodilator properties of ATP, this nucleotide is also able to modulate 
post-junctional sympathetically-mediated vasoconstriction, a property unique amongst 
exogenous vasodilator substances in humans (Figure 3B) (24,26,32).  Our working hypothesis is 
that ATP binds to P2 receptors on the endothelium and this leads to hyperpolarization of 
endothelial and vascular smooth muscle cells which in turn, limits sympathetic vasoconstriction.  
Importantly, the ability to limit post-junctional sympathetic vasoconstriction is a significant 
phenomenon that occurs in actively contracting skeletal muscle and is known as ‘functional 
sympatholysis’.  Given the profound vasodilator capacity of the skeletal muscle vasculature, 
vasoconstriction even within the active muscle is needed in order to prevent a decline in total 
peripheral resistance and thus maintain arterial blood pressure.  In this manner, functional 
sympatholysis permits increased blood flow and oxygen delivery to the active tissue in order to 
support increased metabolism.  It is therefore critical that intravascular ATP possesses dual 
vasomotor properties in that it can facilitate hyperemia by causing direct vasodilation during 
exercise and also act to limit the amount of sympathetic vasoconstriction, thereby preserving 
adequate blood flow to the active tissue during conditions of sympathoexcitation.   
 
DOES INHIBITING ATP SIGNALLING ALIGN WITH THE HYPOTHESIS? 
 Early in vitro data demonstrated that ATP stimulated vasodilation via an endothelium-
dependent mechanism; however, downstream obligatory signaling pathways in humans remained 
uncertain for some time.  In humans, a variety of investigations explored whether the 
endothelial-derived autocoids nitric oxide and prostaglandins explained ATP vasodilation with 
equivocal results being found, even in our own laboratory depending on the timing of inhibition 
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and method of blood flow measurement (5).  Upon critical review of the collective data, it 
appears that up to 20% of the vasodilation stimulated by ATP may be due to NO and PGs in 
humans. 
In contrast, intra-arterial infusion of barium chloride to inhibit inwardly-rectifying 
potassium (KIR) channels reduces ATP-mediated dilation ~50% (Figure 4A) (3).  Activation of 
KIR channels is understood to directly hyperpolarize vascular cells (endothelial and/or smooth 
muscle) (10) as well as amplify hyperpolarization signals originating from adjacent cells (19).  
Importantly, vascular hyperpolarization is the essential underpinning for conducted vasodilation, 
or specifically, the ability for electrical signals to rapidly spread throughout the vasculature and 
cause profound vasodilation (33).  Taken together, these data are consistent with the hypothesis 
that intravascular ATP and the ensuing signaling cascade is a robust regulator of vascular tone.   
Recently, we have inhibited KIR channels during muscle contractions in humans (7).  In 
our model of forearm exercise, there is no impact on hyperemia during steady-state exercise 
when the synthesis of NO and PGs are antagonized; however, inhibiting KIR channels 
significantly reduces exercise hyperemia by ~30% (Figure 4B).  The magnitude of this effect is 
profound and to date represents the largest impact on forearm exercise hyperemia via 
pharmacological antagonists of single or multiple vasodilator pathways (20).   
Consistent with the significant impact on exercise hyperemia of inhibiting KIR channels, 
hyperpolarization and resultant conducted dilation may be crucial to the robust vasodilation and 
modulation of sympathetic vasoconstriction that occurs in the microvasculature during muscle 
contraction (33).  Taken together, activation of KIR channels resulting in hyperpolarization of the 
vasculature appears to be crucial to vasomotor regulation during exercise and importantly, ATP 
signals via this mechanism. 
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Regarding hypoxic vasodilation, we have previously explained local mechanisms of 
hypoxic vasodilation in humans via inhibition of NO and PGs (27).  Our current studies are 
attempting to determine whether hyperpolarizing pathways are also involved in the hypoxic 
response, particularly that which occurs when hypoxia is combined with exercise, which cannot 
be completely attributed to NO derived from nitric oxide synthase and PGs (6).  Given that some 
data indicate a portion of ATP-mediated vasodilation can signal via NO and PGs, it still remains 
a possibility that ATP may mediate the rise in blood flow that allows for perfusion matching in 
circumstances of decreased oxygen supply.  
 
INTRAVASCULAR ATP IN HUMANS OF HIGH DISEASE RISK 
 Thus far, we have built support for the hypothesis that ATP is involved in vascular 
control during mismatches of oxygen delivery and demand in young healthy humans.  As 
depicted in Figure 5A, exercise increases tissue oxygen demand whereas hypoxia decreases 
tissue oxygen supply.  Additionally, during exercise CO2 increases and acidosis occurs.  These 
stimuli, along with exercise-induced mechanical factors and increases in blood temperature can 
serve as stimuli for ATP release from intravascular cell sources.  Circulating extracellular ATP 
then signals for increased vasodilation and blunts sympathetically-mediated vasoconstriction.  
Both actions increase red cell supply and therefore oxygen delivery to the tissue in need.  The net 
hyperemic response works in a negative feedback manner to limit the original oxygen deficit and 
thus a steady-state homeostasis is reached until exercise or hypoxic exposure changes or ceases.   
  Investigations to date have largely focused on the role of extracellular ATP in vascular 
control of young healthy humans.  As such, studies in older individuals (>60 years of age) and 
patient populations to determine vasomotor responsiveness to ATP and/or the level of 
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extracellular ATP release into the bloodstream are limited, despite these populations being at an 
increased risk for cardiovascular morbidity and mortality.  Nevertheless, evidence from our 
laboratory demonstrates an intact vasodilator responsiveness and sympatholytic capacity of 
exogenous ATP at rest in the forearm of aged humans despite the presence of classic ‘endothelial 
dysfunction’ (23,24).  Similarly, in the leg vasculature of diabetic humans, both dilator 
responsiveness and sympatholytic capacity of exogenous ATP appear to be largely preserved 
(35).  It should be noted that preserved vasodilator capacity to ATP with advanced age is not a 
universal finding (29), however at present we interpret the existing data to indicate that the net 
vasomotor responses to intravascular ATP remains generally intact with age and in certain 
disease populations.   
 With regard to measuring endogenous plasma [ATP] in high-risk humans at rest or 
during mismatched oxygen supply and demand conditions, very few studies have been 
published.  In a recent study from our laboratory, we demonstrated that older healthy humans 
have reduced blood flow due to impaired local vasodilation during both graded handgrip exercise 
and systemic hypoxia relative to young adults, and this was associated with impaired increases in 
plasma [ATP] with age (Figure 6) (25).  Further, we demonstrated that elevated ATP catabolism 
during the stimulus was not responsible for the low plasma [ATP] values in older adults, but 
rather isolated erythrocytes from this population fail to release a significant quantity of ATP in 
response to hemoglobin deoxygenation at levels observed during muscle contraction and 
systemic hypoxia (Figure 7A).  Similarly, erythrocytes obtained from type II diabetic patients 
fail to release ATP in response to deoxygenation (Figure 7B) (34).  Impaired erythrocyte release 
of ATP has also been observed in pulmonary hypertension, cystic fibrosis, and sickle cell 
patients, all conditions typically associated with dysfunctional vasomotor control at rest and 
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presumably during oxygen mismatch, although the latter has not been completely determined 
(11).   
 Collectively, we propose the overall scheme (Figure 5B) that in older and diseased 
individuals, the failure to adequately increase intravascular [ATP] partially explains attenuated 
exercise and hypoxic vasodilation (24,25) as well as an impaired ability to modulate sympathetic 
vasoconstriction  (24) in these populations.  Whereas in young healthy adults ATP functions to 
assist matching of oxygen delivery to demand in a homeostatic function, this feedback control 
system is defective in aged or diseased individuals and fails to regulate blood flow and oxygen 
supply, thus allowing the oxygen mismatch to persist or become exacerbated.  
 
SUMMARY  
 The regulation of muscle blood flow during conditions of mismatched oxygen delivery 
and demand is a complex interaction of a variety of factors including neuronal signals and local 
chemical and mechanical stimuli.  Here, we have reviewed the recent literature that suggests 
ATP may be an important local signaling molecule in this regard as it fits the aforementioned 
criteria for likely candidates of vascular control during physiological stress.  First, exercise and 
hypoxia evoke measureable elevations in skeletal muscle plasma ATP.  This ATP is expected to 
be of intravascular origin and is appropriately located to increase blood flow and oxygen delivery 
to tissues of metabolic need.  While not extensively discussed in this review, several inactivation 
mechanisms are in place to regulate plasma ATP concentrations (e.g. ectonucleotidases) and thus 
finely control the resulting vasoactive action. Second, exogenous administration of ATP mimics 
the predicted responses of exercise specifically in terms of robust vasodilation and the ability to 
modulate sympathetic vasoconstriction.  Third, while specific and selective inhibition of 
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intravascular ATP and the concomitant vascular signaling during exercise remains difficult, 
pharmacology known to significantly blunt ATP-induced hyperemia in quiescent muscle 
correspondingly results in profound attenuation of exercise hyperemia in humans (~30%).  
Further, we propose that due to their impaired ability to release ATP, older healthy and diseased 
humans exhibit compromised vascular control during cases of mismatches in oxygenation and in 
turn this leads to further impairments in oxygen delivery.  Future research should be aimed at 
determining therapeutic interventions to improve ATP release and increase intravascular ATP in 
these at-risk populations.  The resulting normalized vascular control may mitigate the current 
elevated risk of cardiovascular mortality and acute cardiovascular events in these populations. 
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FIGURE LEGENDS 
 
Figure 1.  Increased venous plasma [ATP] draining skeletal muscle during exercise and 
hypoxia  
Progressive rhythmic handgrip [% of maximal voluntary contraction (MVC)] (A) or single-leg 
knee extensor (B) exercise significantly increases venous plasma [ATP].  Exposure to systemic 
hypoxia (inspired O2 fraction ~10%; hemoglobin O2 saturation ~80%) results in significantly 
increased plasma [ATP] as measured by blood sample from deep forearm vein (C) and via 
intravascular microdialysis in the femoral vein (D) of young healthy humans.  Differences in 
measurement technique contribute to discrepant absolute values between studies (see text for 
details).  *P<0.05 vs normoxia/rest; ‡P<0.05 vs 5% MVC exercise.  [Panels A and C adapted 
from (25). Copyright © 2012 American Heart Association. Used with permission. Panels B and 
D adapted from (30).  Copyright © 2011 The Physiological Society. Used with permission.] 
 
Figure 2.  Source of and stimulus for increased venous plasma [ATP] during exercise 
Regarding the source of intravascular ATP, two minutes of lower body negative pressure 
(LBNP) at -40 mmHg to engage the baroreflex and stimulate increased sympathetic nervous 
system activity did not significantly alter venous plasma [ATP] at rest (A) or during moderate-
intensity (15% maximal voluntary contraction) rhythmic handgrip exercise (Ex; B).  When 
forearm blood flow is occluded (Occl) during exercise and muscle contractions continue, ATP is 
significantly reduced from steady-state exercise (SS Ex) (C).  When perfusion is prevented with 
occlusion prior to exercise, resting [ATP] does not change and exercise fails to increase [ATP] 
(D).  Taken together, these findings suggest the increase in venous plasma [ATP] during exercise 
arises from cells within or in contact with the blood.   n.s. – not significant; *P<0.05 vs rest; 
†P<0.05 vs steady-state exercise.  [Adapted from  (22). Copyright © 2013 The Physiological 
Society. Used with permission.]  Regarding the stimulus for ATP release, studies in whole blood 
samples (E) and plasma measures (F) demonstrate a strong correlation between hemoglobin 
deoxygenation and increased ATP release.  In Panel E, whole blood samples were drawn from 
Sprague-Dawley rats and then exposed to varying gas concentrations via solution chamber.  In 
Panel F, blood samples were obtained from the human femoral vein at rest and during 
incremental knee-extensor exercise and plasma was separated.  Subjects were exposed to 
differing systemic atmospheric conditions including normoxia (inspiratory oxygen fraction FIO2 
21%), hypoxia (FIO2 ~10%), hyperoxia (FIO2 100%) and carbon monoxide (CO, circulating 
FCOHb ~21%) breathing with normoxia in order to vary oxygen saturations. Panel E reprinted 
from (18). Copyright © 2001 American Physiological Society. Used with permission.  Panel F 
reprinted from (16).  Copyright © 2002 American Heart Association. Used with permission.] 
 
Figure 3.  Vasomotor responses of intravascular ATP in humans 
(A) Intra-arterial (femoral) infusion of exogenous ATP (black line) is capable of causing 
profound vasodilation (increased vascular conductance), similar to that which occurs with 
maximal exercise (grey line; incremental cycling exercise). *P<0.05 vs rest. [Adapted from (32) 
Copyright © 2004 The Physiological Society. Used with permission.].  (B)  Exogenous ATP is 
capable of modulating sympathetically-mediated (PE, phenylephrine, α1-adrenergic agonist) 
vasoconstriction (decreased vascular conductance), similar to that which occurs during 
moderate-intensity handgrip exercise (15% maximum voluntary contraction).  Here, adenosine 
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(white bars) is used as a high-flow control vasodilator in quiescent tissue and is not 
sympatholytic. *P<0.05 vs Pre-PE; †P<0.05 vs adenosine.  [Data from (26) Copyright © 2008 
The Physiological Society. Used with permission.].   
 
Figure 4.  Similar downstream signaling pathways of exogenous ATP and exercise in 
humans 
(A) Exogenous ATP-mediated vasodilation (increased vascular conductance) in the forearm 
occurs primarily (~50%) via activation of inwardly-rectifying potassium (KIR) channels as 
determined via intra-arterial barium chloride (BaCl2) to inhibit KIR channels *P<0.05 vs control. 
[Reprinted from (3) Copyright © 2012 The Physiological Society. Used with permission.].  
Similarly, as seen in panel B, a significant portion (~30%) of the hyperemic response to mild 
intensity (10% maximal voluntary contraction) rhythmic handgrip exercise is attenuated with 
infusion of BaCl2, indicating a significant role for KIR channels in this vasomotor response.  This 
inhibition occurs both in the rapid response to muscle contractions at the onset of exercise as 
well as during steady-state hyperemic conditions.  Additional inhibition of Na
+
-K
+
-ATPase via 
intra-arterial ouabain does not further impact exercise hyperemia.  [Reprinted from (7) Copyright 
© 2014 American Physiological Society. Used with permission.].   
 
Figure 5. Intravascular ATP as a regulator of vascular tone during conditions of 
mismatched oxygen supply and demand 
Overall schematic of our working hypothesis on the role of ATP in vascular control.  (A) In 
young healthy individuals, during exercise oxygen demand is increased, whereas during hypoxia 
oxygen supply is diminished.  Both instances result in a mismatch that decreases the fraction of 
oxyhemoglobin (FO2Hb) and exercise increases CO2 resulting in acidosis.  These conditions, 
along with exercise-induced mechanical factors and increases in blood temperature serve as 
stimuli for ATP release from cell sources within or in contact with the blood.  Circulating plasma 
ATP then signals for increased vasodilation and blunts sympathetically-mediated 
vasoconstriction.  Both actions increase red cell supply and therefore oxygen delivery to the 
tissue in need.  The net hyperemic response thus works in a negative feedback manner (red 
dashed line) to limit the original oxygen deficit and reach a steady-state homeostasis until 
exercise or hypoxic exposure changes or ceases.  (B) In older or diseased populations, failure to 
adequately increase [ATP] comprises this regulation leading to exacerbated mismatches (positive 
feedback indicated by solid blue line) in oxygen delivery to demand which can result in relative 
ischemia.   
 
Figure 6.  Older individuals demonstrate impaired vascular control and are unable to 
increase plasma [ATP] during conditions of oxygen mismatch 
Relative to young individuals, older individuals exhibit attenuated hyperemia (A) and fail to 
increase [ATP] (B) during progressive rhythmic handgrip exercise (% maximal voluntary 
contraction, %MVC).  Similarly, older adults have attenuated hyperemic responses (C) and fail 
to significantly increase [ATP] (D) in response to systemic hypoxic exposure (inspired O2 
fraction ~10%; hemoglobin O2 saturation ~80%).  *P<0.05 vs rest/normoxia; †P<0.05 vs young; 
‡P<0.05 vs 5% and 15% within young.  [Adapted from (25).  Copyright © 2002 American Heart 
Association. Used with permission.] 
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Figure 7.  Isolated erythrocytes from older and diseased populations fail to release ATP in 
low oxygen conditions 
(A)  Isolated erythrocytes obtained from young individuals release ATP upon exposure to low 
oxygen gas, whereas this does not occur in cells obtained from older individuals. *P<0.05 vs 
normoxia [partial pressure of oxygen (PO2) ~110mmHg]; †P<0.05 vs young.   [Reprinted from 
(25). Copyright © 2012 American Heart Association. Used with permission.].  (B) Similarly, 
hypoxia-induced ATP release is attenuated in erythrocytes obtained from individuals with type II 
diabetes mellitus as compared to healthy control subjects.  *P<0.05 vs 15% O2; †P<0.05 vs 15% 
and 4.5% O2. [Adapted from (34) Copyright © 2012 American Physiological Society].  In both 
studies, tonometry was used to expose isolated erythrocytes to varied O2 concentrations, 6% CO2 
and N2 balance. 
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